ETFs Holding ONCE »    ONCE Historical Stock Prices »
ONCE News Video: Mon, Feb 25, 2019, 12:29 PM — Monday's ETF Movers: XBI, GDXJ

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Spark Therapeutics is a gene therapy company. Co. is engaged in the field of gene therapy, which focuses on overcoming the effects of a malfunctioning, disease-causing gene. Co. has a pipeline of gene therapy product candidates that are for the retina, the liver and the central nervous system. Co.'s product, LUXTURNA™ (voretigene neparvovec-rzyl), has been approved for the treatment of patients with viable retinal cells and confirmed biallelic RPE65 mutation-associated retinal dystrophy. SPK-7001 is Co.'s main product candidate for the treatment of choroideremia (CHM). Co. has received orphan product designation for SPK-7001 for the treatment of CHM in the U.S. and the European Union. Self directed investors in Spark Therapeutics Inc will be interested in keeping up with all Spark Therapeutics Inc news they can find, both ONCE news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on ONCE. At RediNews, we simplify this task by presenting both ONCE news releases originating from Spark Therapeutics Inc itself, and ONCE news from a variety of media outlets. Visitors can browse this news online and through our ONCE RSS news feed.


ONCE News — Articles, Videos, & Press Releases

Notable Friday Option Activity: ONCE, SQ, PYPL
Friday, May 17, 2019, 3:22 PM — Stock Options Channel
Notable Friday Option Activity: CNOB, BRKR, ONCE
Friday, April 26, 2019, 3:20 PM — Stock Options Channel
Notable Thursday Option Activity: BOX, CNSL, ONCE
Thursday, April 18, 2019, 3:19 PM — Stock Options Channel
Roche's (RHHBY) Q1 Sales Strong on Solid Demand for New Drugs
Thursday, April 18, 2019, 8:29 AM — Zacks
Oversold Conditions For Spark Therapeutics (ONCE)
Friday, April 12, 2019, 12:00 PM — Dividend Channel
Ophthotech Gets Rights to Gene Therapy for BEST Disease
Friday, April 12, 2019, 8:02 AM — Zacks
Biotechnology Market on a Tear: 5 ETFs in Spotlight
Thursday, April 11, 2019, 1:33 PM — Zacks
Health Day Checkup of Medical ETFs: 5 Top Picks
Friday, April 5, 2019, 6:00 AM — Zacks
Sangamo Rises on Positive Phase I/II Hemophilia Study Data
Wednesday, April 3, 2019, 8:15 AM — Zacks
XBI, ONCE, PBYI, PTLA: Large Inflows Detected at ETF
Tuesday, March 19, 2019, 10:53 AM — ETF Channel
Short Interest In Spark Therapeutics Plummets 57%
Tuesday, March 12, 2019, 11:23 AM — Market News Video
Notable ETF Outflow Detected - XBI, ONCE, PBYI, PTLA
Monday, March 11, 2019, 10:46 AM — ETF Channel
Biogen to Acquire Gene-Therapy Company Nightstar for $800M
Tuesday, March 5, 2019, 3:53 PM — Zacks
Spark Therapeutics Larger Than S&P 500 Component Under Armour
Wednesday, February 27, 2019, 4:39 PM — Market News Video
Biotech ETFs Jump on Roche-Spark Deal
Tuesday, February 26, 2019, 10:15 AM — Zacks
Company News For Feb 26, 2019
Tuesday, February 26, 2019, 8:30 AM — Zacks
Spark Therapeutics Reaches Analyst Target Price
Tuesday, February 26, 2019, 8:12 AM — ETF Channel
5 Gene Therapy Stocks to Enrich Your Portfolio
Tuesday, February 26, 2019, 7:54 AM — Zacks
Roche (RHHBY) to Acquire Spark Therapeutics for $4.8 Billion
Monday, February 25, 2019, 7:31 AM — Zacks
First Week of ONCE April 18th Options Trading
Friday, February 22, 2019, 10:36 AM — Stock Options Channel
Noteworthy Wednesday Option Activity: KODK, DF, ONCE
Wednesday, February 20, 2019, 3:18 PM — Stock Options Channel
The Math Shows JKK Can Go To $223
Wednesday, January 23, 2019, 7:25 AM — ETF Channel
First Week of February 15th Options Trading For Spark Therapeutics (ONCE)
Tuesday, January 8, 2019, 10:37 AM — Stock Options Channel
Analysts Forecast 39% Upside For JKK
Thursday, December 20, 2018, 7:56 AM — ETF Channel
Implied ESML Analyst Target Price: $31
Friday, November 9, 2018, 7:36 AM — ETF Channel
Spark Therapeutics Becomes Oversold (ONCE)
Monday, October 22, 2018, 11:54 AM — Dividend Channel
Interesting ONCE Put And Call Options For November 16th
Wednesday, October 10, 2018, 11:25 AM — Stock Options Channel
FAD's Underlying Holdings Could Mean 11% Gain Potential
Wednesday, October 3, 2018, 7:28 AM — ETF Channel
Commit To Purchase Spark Therapeutics At $45, Earn 12.8% Annualized Using Options
Friday, September 21, 2018, 1:02 PM — Stock Options Channel
Spark Therapeutics Enters Oversold Territory (ONCE)
Monday, September 17, 2018, 4:31 PM — Dividend Channel
Analysts Anticipate JKK Will Reach $229
Friday, August 10, 2018, 9:22 AM — ETF Channel
Notable Tuesday Option Activity: NLS, MXL, ONCE
Tuesday, August 7, 2018, 3:19 PM — Stock Options Channel
Oversold Conditions For Spark Therapeutics (ONCE)
Tuesday, August 7, 2018, 11:58 AM — Dividend Channel
Short Interest In Spark Therapeutics Declines 11%
Thursday, July 12, 2018, 11:46 AM — Market News Video
First Week of ONCE August 17th Options Trading
Friday, June 22, 2018, 10:39 AM — Stock Options Channel
ONCE Crosses Above Average Analyst Target
Wednesday, June 20, 2018, 7:54 AM — ETF Channel
Commit To Purchase Spark Therapeutics At $60, Earn 23% Annualized Using Options
Friday, June 15, 2018, 12:00 PM — Stock Options Channel
XBI, LOXO, IMMU, ONCE: Large Outflows Detected at ETF
Thursday, May 24, 2018, 10:58 AM — ETF Channel
ONCE is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

ZBH News

Anyone with a stock market portfolio cares about more than stock market price information, or the historical stock price of the stocks they own, or whether their stocks show up on the latest top ten stocks list. They also care about news. What news is coming out of the company, and, what are third party articles and videos saying? Your web site content may feature an excellent stock market screener and nice web page chart graphics, but if you are lacking in the news offerings you are missing a big reason for visitors to return to your site. People form habits, one of which is to check the weather forecast, another is to check the stock market price levels of the major indices, and a third is to check the news for their stocks they own. So don't pass up integrating our free RediNews RSS news feeds. Simply navigate to any RediNews news page by specific ticker symbol or by sector, then click the RSS icon for that news page to reach the associated RSS feed (the icon will look like this): .

ONCE News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.